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Abstract 10 
We use epidemiology whenever we consider the management of sheep health. To measure a disease, we need a 11 
precise and unique case definition and we often use diagnostic tests to assist in defining a disease. Diagnostic tests 12 
are not always accurate and it is necessary to consider the decisions that will be taken based on the result of testing 13 
to decide the most useful approach to interpret a test based on its test sensitivity and specificity and the prevalence 14 
of the disease in a flock. This is particularly important when decisions on culling or selection of sheep to attain e.g. 15 
freedom from disease are made on the basis of test results. Infectious diseases spread within and between flocks in a 16 
variety of ways; brought-in sheep are the most likely source for introduction of a new pathogen or strain of  17 
pathogen. When a pathogen enters a naïve flock, it spreads through susceptible sheep and persists in the flock whilst 18 
there are susceptible sheep that can be infected. Pathogens use a variety of techniques to persist, including a change 19 
in the pathogen itself, an alteration in infected hosts that enable them to remain infectious for prolonged periods or 20 
to be re-infected or persist in another host species or the environment. We need to consider these strategies to decide 21 
whether elimination or control of a particular pathogen is more likely to be effective. Whatever the flock control 22 
strategy treatment of diseased individuals is essential for their welfare and can also protect the rest of the flock if 23 
treatment reduces the infectious period. Decisions on management of disease are based on our knowledge of the 24 
flock and its management and the evidence-base for various control strategies. There are now formal techniques for 25 
evaluating the evidence base that can assist in evaluating evidence. One area where we need to evaluate evidence is 26 
on cause. It is not possible to prove anything, but we can use the weight of evidence to evaluate likely cause. There 27 
are nine aspects of association with which we can evaluate a piece of evidence; these are: strength, consistency, 28 
specificity, temporality, dose response, plausibility, coherence, experiment and analogy. 29 
 30 
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 33 
1. Introduction 34 
 35 
There are two key areas of sheep health where an understanding of epidemiological principles 36 
can assist in decision making. This first is in diagnosing disease and the second is in controlling 37 
disease. Whether we realise it or not, we use epidemiology -the distribution, determinants and control 38 
of diseases in populations (Thrusfield, 1995)-whenever we consider the management of sheep health. 39 
In this article, I discuss diagnosing individuals and consider case definition and the 40 
interpretation of diagnostic tests. I give some theoretical background on infectious disease processes 41 
to help explain some of the challenges that we face when we consider control of sheep diseases. Some 42 
aspects of control require us to establish cause and thus, I cover an approach that we can use to move 43 
from establishing a statistically significant link between an exposure and a disease and inferring cause.  44 
Throughout I have given examples from my own research. This is not because these are the 45 
best examples, but because I am most familiar with them. Inevitably, this article is not exhaustive and, 46 
also inevitably, it is opinionated. 47 
 48 
2. Case-definition 49 
 50 
When we manage sheep diseases, we can consider two broad categories of disease, infectious 51 
and non-infectious. For both types of disease, we need case-definitions for each disease. Case-52 
definitions need to be precise and unique; if we wish to compare across flocks, we need to ensure that 53 
the case-definition is consistent between flocks. For some diseases, case-definitions are relatively 54 
straightforward for diagnostic purposes, although not always well-recorded in sheep health 55 
management, but sometimes it is difficult to define a disease, and particularly to be consistent across a 56 
population of flocks. 57 
 58 
3. Diagnosing disease 59 
 60 
Imagine that we have a scenario where some sheep have aborted. There are several causes of 61 
abortion in sheep and we need to determine the cause(s) for this particular flock. We can take a history 62 
of the affected sheep: gestation stage at the time of abortion, clinical signs in ewes which aborted, 63 
macroscopic appearance of lambs and placentae, past history of abortions in the flock, introduction of 64 
new sheep into the flock (see below under introduction of pathogens). We can take the products of 65 
abortion and blood samples for further diagnostic tests. Our clinical observations and case history 66 
provide evidence to assist in making a diagnosis, but laboratory tests are needed to confirm the 67 
diagnosis. 68 
 69 
4. How many sheep should we investigate? 70 
 71 
We need to consider how many sheep we should investigate, which sheep and how will we be 72 
certain of our final diagnosis. Typically, we would sample six affected sheep. Six turns out to be a 73 
good number statistically (Green, 1999), in that it is the minimum number required if all six are 74 
different from normal (Wilcoxon rank test; Petrie and Watson, 2008). This approach relies on all six 75 
sheep having the same abnormality and being certain that this is different from normal without taking 76 
samples from ‘normal’ sheep and of course that there are six sheep that have aborted. If this is not the 77 
case, we have less certainty (see below under sensitivity and specificity). We can improve our 78 
precision of diagnosis by taking blood samples from sheep that have not aborted and using them as 79 
controls, as well as by taking blood samples from sheep that aborted and those that did not after two 80 
weeks (having recorded their permanent identity, in order to be able to find them again!), which 81 
supports an investigation as to whether there has been a change in antibody levels to likely infectious 82 
diseases only in sheep that aborted. 83 
 84 
5. Minimising costs 85 
 86 
I would not consider making a diagnosis on clinical signs and history alone: although the 87 
clinical presentation of an abortion might have ‘characteristic signs’ or have been seen on the farm 88 
previously; there might be more than one cause of abortion and clinical signs are notoriously variable. 89 
This holds true for all diagnoses where micro-organisms are involved; e.g. a bloody milk sample in a 90 
sheep with mastitis might indicate infection by Staphylococcus aureus, but it may also indicate 91 
infection by Mannheimia haemolytica or anyone of many other pathogens. 92 
However, there is a need to minimise the costs for the farmer. One way to do this is to take all 93 
the relevant samples that we need at each visit, but to only process them as necessary in order to reach 94 
a diagnosis. However, it is important to make a precise diagnosis, because the approach to control will 95 
vary depending on the cause of disease, not just the presenting signs. Ultimately, we might cost a 96 
farmer much more money by not honing the diagnosis; for example, if a disease is suspected and a 97 
vaccine then used without confirmation of the disease, and this were a live attenuated vaccine then the 98 
micro-organism (even be it in mutated form) is being introduced into the flock. This would be totally 99 
inappropriate if the pathogen was not already on the farm, and could lead to increased disease. 100 
 101 
6. Test sensitivity and specificity 102 
 103 
It is easy to act on the results of diagnostic tests (clinical signs, laboratory tests or a 104 
combination of both) without reflecting on their accuracy. A perfect test that correctly identifies all 105 
diseased sheep as diseased and all non-diseased sheep as non-diseased is the ‘gold standard’. For 106 
many diseases there is no ‘gold standard’ (at least not in live sheep) and we use tests that do not 107 
always produce correct results. 108 
There are several other measures that we need to be aware of, in order to assess usefulness and 109 
appropriateness of a diagnostic test. Two of these are its sensitivity and specificity. The sensitivity 110 
indicates the proportion of truly affected sheep that are detected by the test. The specificity indicates 111 
the proportion of truly negative sheep that the test defines as negative. For most practical purposes, the 112 
sensitivity and specificity of a test are independent of prevalence of disease and consistent across 113 
populations. Manufacturers of a diagnostic test should provide its sensitivity (tested on known 114 
infected individuals) and specificity (tested on known uninfected individuals) and a reference to how 115 
these were estimated. So, if we have a (fictitious) test for toxoplasmosis with a sensitivity of 85% and 116 
a specificity of 95%, and if 100 sheep in a flock of 1000 truly have toxoplasmosis, then we can expect 117 
the test to identify 85 out of the 100 truly infected sheep and 855 out of the 900 truly uninfected 118 
sheep: a further 15 infected sheep would be defined as uninfected (i.e. 15/1000 false negatives) and 45 119 
uninfected sheep would be defined as infected (i.e. 45 / 1000 will be false positives), hence our test 120 
would tell us that 130 sheep have toxoplasmosis and 870 do not. 121 
If we forget to consider the test sensitivity and specificity, we might make an incorrect 122 
decision about the management of an individual or a flock. For example, if we suspect that there is 123 
Toxoplasma abortion in a flock and we test one sheep that truly has toxoplasmosis with our fictitious 124 
test above, then there is a 15% chance that the test result would be negative. By testing two sheep, this 125 
error reduces to <3% (0.15^
2
); by testing six sheep, there is <0.01% (0.15^
6
) risk of incorrectly 126 
defining the flock as negative. So, by testing six sheep and getting at least one positive individual, we 127 
can be fairly certain that the flock has Toxoplasma abortion. 128 
For an individual ewe, by retesting the same sheep with the same test (assuming that the test 129 
error is chance- rather than a host specific-characteristic), we again increase our precision to <3% 130 
error. Suppose a ewe is truly negative, at the first test 5% of truly negative sheep will have a test 131 
positive result. The probability that a sheep tests negative twice, when she is positive is 0.05^
2
, thus 132 
we have a 2.5% error that we say a truly positive sheep is negative for Toxoplasma infection. What do 133 
we do when a sheep tests positive to one test and negative to another? We have to decide whether we 134 
want to raise the sensitivity (any test positive) or specificity (any test negative) to define diseased and 135 
non-diseased sheep. We can also use a different second test with a different sensitivity and specificity. 136 
For example, we might choose a sensitive test initially to ensure that all truly positive sheep are 137 
identified, accepting that some sheep that are false positives will be included, then use a more specific 138 
test to identify the truly positive sheep. 139 
 140 
7. Test sensitivity and specificity are linked 141 
 142 
For most tests with a cut-off value that determines a positive or negative result, as sensitivity 143 
increases specificity decreases (Fig. 1). If we know this information, then we can use it to our 144 
advantage. We can alter a diagnostic test’s sensitivity and specificity by altering the cut-off value used 145 
to define a positive and negative test result. This is not to suggest anything untoward! 146 
This might be useful if we wish to use a test for a certain procedure. For example, if we want 147 
to select only disease-free individuals, we can choose a cut-off that makes a test highly sensitive, so 148 
that all truly affected individuals are indeed test-positive (i.e. 100% sensitivity). Inevitably, the test 149 
specificity will be low and there will be individuals that are false-positive. However, we can select our 150 
disease-negative sheep from the group that are test-negative with a high degree of confidence that they 151 
are truly negative. Conversely, there are occasions when we would want a highly specific test. If we 152 
decide to cull pedigree sheep with a disease, we might not wish to cull sheep that are true negatives 153 
for this disease, because of the financial cost with no benefit, so we might choose a specific test. This 154 
does of course raise the concern that we might fail to eliminate the disease! 155 
 156 
8. Predictive value of a test 157 
 158 
Repeating a test or using a second test on a subset of sheep ‘works’, because by taking a group 159 
of sheep already positive to a test we are increasing the proportion of the sample that are test-positive, 160 
i.e. we ‘increase’ the prevalence of the disease. The result of this is that we increase the positive 161 
predictive value of the test. The positive predictive value of the test is the probability that a sheep has 162 
a disease given that it has a positive test result. The positive predictive value of a diagnostic test 163 
increases as prevalence increases for a set sensitivity. The negative predictive value of a test increases 164 
as the prevalence of a disease decreases (Fig. 2a). If disease prevalence is very low, then the positive 165 
predictive value of a test is low (Fig. 2b) and vice-versa. This is intuitive, if you take a moment to 166 
think about it, because if we have a test that can give false positive results, we will have positive test 167 
results even in a population free from disease. In this circumstance, 100% of test positive results are 168 
false positives; e.g. using our test for toxoplasmosis above with a sensitivity of 85% and specificity of 169 
95%, if the prevalence of disease is 5%, then <50% of the 90 test-positive individuals will be true 170 
positives. This has implications if our decision is to remove these individuals from the flock. We can 171 
try to reduce the proportion of false positive sheep culled unnecessarily, if we use further tests. It is 172 
also unwise to use an imprecise test in such a situation, because it is not possible to know which of the 173 
test positives are truly negative; for example, the current test for caseous lymphadenitis has relatively 174 
low sensitivity and specificity in sheep and thus, the proportion of the flock removed that are 175 
uninfected, particularly towards the end of an elimination programme is too high to make this a 176 
feasible approach (O’Reilly et al., in press). 177 
 178 
9. Estimating absence of disease - is a disease present in a flock? 179 
 180 
One question of interest for flock health schemes is whether a disease is present in a flock. If 181 
we wish to be confident that a disease is absent from a flock, we could test every individual in the 182 
flock. This is usually prohibitively expensive and unnecessary if we are prepared to compromise 183 
slightly. We can use a statistical formula to estimate how many sheep we need to sample to be sure 184 
that if a disease is present, it is present at below a certain prevalence with a certain confidence around 185 
this prevalence, for example <1% of animals infected ±0.5% precision. This is more or less the 186 
calculation used by countries to estimate freedom from disease (Thrusfield, 1995). 187 
 188 
10. Populations and individuals 189 
 190 
Good management of sheep flocks will use information from the whole flock on health (e.g. 191 
disease status, vaccinations used, diagnoses and treatments, on-farm deaths, abnormalities observed at 192 
the abattoir (Green et al., 1994; Green et al., 1997)) and productivity (e.g. lambing percentages, lambs 193 
born alive, lambs born dead, body condition of ewes, cull rates, carcass quality (). However, flocks 194 
vary in the amount and quality of information available and its accessibility. Pedigree flocks might 195 
have more information on planned breeding and flocks in health schemes will have information on 196 
diseases that are under surveillance. 197 
This whole flock information is of use to assess likely productivity of the flock and 198 
profitability, if it can be tied in with fixed and variable costs. It can also be used to monitor flock 199 
health and target improvements in, for example, lambing percentage or growth rate. Monitoring the 200 
flock also assists us in identifying and targeting individuals for special care, for example 201 
supplementing feed of thin ewes to prevent pregnancy toxaemia or treating individual diseased sheep. 202 
No flock can ever be free from all disease and so it is crucial that whole flock management does not 203 
become an alternative to care of individuals in the flock. For infectious diseases, management of 204 
individuals (from quarantine to rapid treatment and isolation) can also protect the flock and so can be 205 
an efficient way of controlling disease, particularly those where there is no effective vaccine. An 206 
appreciation of how infectious diseases transmit aids understanding of the role of individuals in 207 
allowing pathogens to persist in a flock. This is described in the sections below. 208 
 209 
11. Introduction of a new pathogen 210 
 211 
A new pathogen can be introduced into a naïve flock via infectious sheep, infectious other-212 
host species or infectious host products, such as skin, milk or wool. It can also enter through vectors, 213 
such as insects, or via fomites, such as vehicles or boots. Infectious conspecifics (sheep in this case) 214 
are the most likely source of infection and this is why quarantine is a very useful procedure. Note that 215 
quarantine facilities therefore, need to be sufficiently far from the flock with separate care for 216 
quarantined sheep to prevent infection transmitting to the main flock. To ensure that quarantine is 217 
successful it needs to be for a sufficiently long duration to prevent introduction of the pathogen. In this 218 
time, the pathogen will either die out or the disease will manifest and the sheep can be managed 219 
accordingly (treatment, culling, delayed entry to the flock). There are some pathogens for which 220 
quarantine is unlikely to be successful (e.g. scrapie), because of a long incubation period. All of the 221 
above also holds true for re-introduction of an existing pathogen, although we might not notice re-222 
introduction if a pathogen is already present it is an important route for persistence of pathogens 223 
within a flock. In this case, pathogens are moving in a meta-population (flocks of sheep linked by 224 
some degree of contact). A topical example would be re-introduction of roundworms, particularly 225 
with the concern of anthelminthic resistance. 226 
 227 
12. Spread of a new pathogen within a flock 228 
 229 
Once in a flock, the pathogen spreads through the susceptible sheep by one or more routes 230 
(e.g. respiratory, oral-faecal, vector borne). We can use R0 (the reproduction number), which is the 231 
average number of secondary cases from an infectious individual in a naïve population (Anderson and 232 
May, 1991), as a guide to the spread of the pathogen. R0 might tell us whether on average a pathogen 233 
infects 5 or 50 sheep from one infectious host. It does not tell us the speed with which this occurs; we 234 
need the average infectious period for this. It is also worth remembering that R0 varies in time and 235 
space (that is the value of R0 might vary for different flocks infected with the same pathogen); for 236 
example, O’Reilly and others (2008) described four flocks infected with Corynebacterium 237 
pseudotuberculosis, which all had different estimates of R0. 238 
Hosts can be in a variety of states in relation to a pathogen (Fig. 3). Hosts can be susceptible 239 
or infectious, and depending on the nature of the pathogen and host, the host might die, become 240 
resistant, partially resistant (i.e., they can be infected again), a carrier or susceptible again (Table 1). 241 
The SIR (susceptible, infective or recovered) model is a simplification of this process (Fig. 4). These 242 
schematics can help us understand infectious processes. When we develop models from them we aim 243 
to realise what we do not understand / know (Green and Medley, 2002). They are generally specific to 244 
a particular pathogen and the underlying host structure is an important determinant in how the 245 
pathogen will transmit. 246 
 247 
13. Persistence of a pathogen within a flock 248 
 249 
Once a susceptible population has been exposed to a new pathogen, the proportion of the 250 
population susceptible usually declines and so disease is present at a lower prevalence. It is typically 251 
less severe than when a new pathogen enters a naïve population, this is usually thought to be an 252 
adaptation for persistence: it is in the pathogen’s interest for the host to survive for sufficiently longs 253 
to increase its chances of contacting as many susceptible hosts as possible. Persistence of a pathogen 254 
arises when it remains sufficiently long in a population to encounter new susceptible hosts. Pathogens 255 
can persist in the host, for example herpes viruses or retroviruses, in another host species, for 256 
examples Dichelobacter nodosus persists in sheep, goats and cattle, or in the environment, for 257 
example Salmonella, in order to facilitate persistence (Green, 2007). 258 
 259 
14. The spread of infectious diseases between flocks 260 
 261 
Sheep are typically kept in fairly small populations (flocks). Generally, infectious diseases 262 
cluster within flocks, i.e. occur at a higher or lower incidence than chance when compared with the 263 
population average. The risk of introduction of a new pathogen or re-introduction of an existing 264 
pathogen into a flock is dependent on how the pathogen spreads (as described above) and on how the 265 
populations are connected. This connection of flocks is described as a meta-population structure and 266 
the contact between flocks determines the pattern of transmission of a pathogen between flocks. It is 267 
possible that some pathogens persist by moving between flocks through these contacts and are 268 
repeatedly re-introduced. We have seen this with Porcine Respiratory-Reproductive Syndrome Virus 269 
in pigs (Evans et al., 2008; 2009); in fairly isolated herds with <250 sows, the virus is likely to fade 270 
out of the herd, unless it is re-introduced via an infective pig. 271 
 272 
15. Control of infectious diseases 273 
 274 
Once we understand how a pathogen spreads and persists, we can consider control strategies. 275 
Infectious diseases can be controlled by preventing introduction or re-introduction or by elimination 276 
or by minimising their impact on host health. We can eliminate disease by culling the whole flock if 277 
the pathogen persists in the sheep, rather than in the environment or in other hosts and if the 278 
replacement flock can be sourced from known disease-free stock. We can also eliminate by removing 279 
infected individuals through test and cull strategies. These are most effective when the inter-test 280 
interval is shorter than the latent period and all individuals that are infected are removed before they 281 
become infectious Test and cull is less effective when the infectious period is shortened, but not 282 
prevented and on average one infectious individual must infect less than one other individual to 283 
eliminate disease. They are not successful if the inter-test interval permits normal transmission of 284 
pathogen. When successful, restocking or test and cull strategies lead to a totally susceptible 285 
population and so the flock is very vulnerable to re-introduction of disease. Elimination can also be 286 
achieved by ensuring that there are no susceptible hosts until the pathogen has died out. This is usually 287 
done by vaccination. A vaccine which prevents transmission of the pathogen removes susceptible 288 
individuals and raises herd immunity. This might be sufficient to eliminate the pathogen and 289 
ultimately lead to cessation of use of vaccine. Other vaccines control disease, but are not designed to 290 
prevent transmission of the pathogen and so elimination is not possible. This usually means that 291 
disease is minimised rather than absent. Even quite poor vaccines can be effective if used 292 
strategically. The aim is to ensure that a sufficient proportion of a flock is protected against disease at 293 
all times, in order to protect the flock to the level that provides flock immunity. 294 
Control can also be established without vaccination for some diseases, through managing the 295 
environment to ensure hosts are healthy and well-fed and kept in good conditions (fields or buildings) 296 
and that their exposure to the pathogen is minimised or timed to lead to good immunity without 297 
disease,. Whatever the approach to control the nature of the pathogen, host range, transmission routes, 298 
diagnostic tests, vaccines available and flock attributes need to be considered to decide the best 299 
strategy to optimise control of the disease. 300 
 301 
16. Treatment of individuals 302 
 303 
There is no situation where it is acceptable to neglect individual diseased sheep, because there 304 
is no known prevention or flock control measure. 305 
 306 
17. Relevance to sheep health 307 
 308 
If we understand the process of spread of a pathogen, the infection states of individuals and 309 
the mechanisms for persistence or fade out of pathogens, we can evaluate how best to manage a 310 
pathogen in a flock with the current available evidence. This will be both scientific and experiential 311 
and is often incomplete for diseases of sheep. We aim to optimise health and appreciate what is likely 312 
to be successful in our management of a disease. This will vary by flock and pathogen and by owner / 313 
carer. One example would be management of footrot; we (Kaler and Green, 2008) reported that 314 
farmers vary in their willingness to treat individual sheep with footrot: 20% of farmers in that study 315 
did not do so. For flocks under the care of such farmers, an alternative strategy that minimises 316 
lameness is required that needs to be based on our understanding of the behaviour of the pathogen. 317 
Another example would be control of caseous lymphadenitis. Given our current understanding of 318 
transmission, infectiousness, detection of disease and diagnostic tests, I would suggest that eradication 319 
is. unfeasible (O’Reilly et al, in press). 320 
 321 
18. Evidence-based medicine 322 
 323 
Evidence-based medicine is a combination of a clinician’s expertise and all external relevant 324 
research (Sackett et al., 2006). It is widely used in human medicine, where its main output is review 325 
articles (http://www.cochrane.org), which are produced using a transparent, objective and repeatable 326 
method and which summarise and evaluate the current evidence for treatment of a disease using 327 
individual research papers sourced from throughout the world. Over 5000 conditions from the 328 
management of back pain to eczema to cancer have been reviewed. The aim of the reviews is to use a 329 
systematic and transparent process to evaluate the evidence and thus assist practitioners to remain 330 
informed of best current evidence. This, combined with a practitioner’s skill and knowledge of an 331 
individual patient, should provide the patient with the best treatment. In veterinary medicine, we 332 
discuss the use of ‘evidence-based medicine’, but there are currently no formal collaborations and 333 
standards as there are for human medicine. As the number of research publications in veterinary 334 
science increases, it becomes increasingly difficult to keep abreast of individual pieces of evidence as 335 
they are produced. Hopefully, in the future there will be a similar system for review for veterinary 336 
topics. Until then, we have to do our best to read and evaluate literature germane to our areas of 337 
interest. 338 
 339 
19. On cause 340 
 341 
We need to know how to assess whether an exposure is a likely cause if we are to use 342 
evidence-based medicine. That is, we make our decisions on management and treatment based on the 343 
current evidence available together with our knowledge of the flock. In veterinary medicine, there are 344 
many areas where there is little evidence, but we should use what there is! It is easy over time to 345 
believe that we are managing diseases optimally, because of our own experience and it is important to 346 
challenge what we do as new evidence arises.  347 
In all biological studies we use the results of statistical tests to tell us whether there is an 348 
association between two factors. These associations come from a variety of types of study (Table 2), 349 
from closely controlled experimental studies through to cross sectional observational studies. Each 350 
study design has a particular set of purposes and all will provide statistical associations, however, no 351 
statistical tests for significance (in any discipline from immunology and molecular biology to 352 
epidemiology) provide an answer for the question of proof. We use them to estimate the likelihood 353 
that an association is chance or unlikely to be chance with varying degrees of confidence and if a 354 
measure of association (e.g. relative risk or odds ratio) is estimated we can consider its magnitude. 355 
Beyond that statistics contribute nothing to interpretation of cause - I repeat again, for any scientific 356 
discipline. 357 
Bradford Hill (1965) suggested nine questions that we can ask of results that help with 358 
inferring causality, assuming that we have a ‘significant’ association. These are listed below. I have 359 
used the evidence that we have to date to evaluate whether routine and treatment trimming sheep feet 360 
is beneficial to prevention or recovery from footrot - a contentious issue, at least a few years ago 361 
(Abbott and Lewis, 2005). 362 
 363 
19.1. Strength 364 
 365 
We measure strength of associations with relative risks or odds ratios. It is important to 366 
appreciate how these are calculated (especially odds ratios, which can be misleadingly large), but 367 
generally, the larger these values (further from the baseline positively or negatively) the more strongly 368 
associated an exposure is with a disease. For example, in our research on routine foot trimming, for 369 
every one sheep affected, farmers who routinely trimmed the feet of their sheep twice or more than 370 
twice per year had 1.65 and 2.11 sheep affected respectively (Wassink et al., 2003): this is a moderate 371 
association compared with e.g. the 20-fold risk reported between smoking and lung cancer (Bradford 372 
Hill, 1965). 373 
 374 
19.2. Consistency 375 
 376 
‘Has it been repeatedly observed by different persons, in different places, circumstances and 377 
times?’ We have repeatedly seen a link between routine foot trimming and increased prevalence of 378 
lameness, footrot and interdigital dermatitis (Wassink et al., 2003, 2004; Green et al., 2007; Kaler and 379 
Green, 2009). There is evidence that trimming the feet of sheep lame with footrot, there was a delay in 380 
healing of lesions in the UK and Australia (Kaler et al, 2009; Jordan et al., 1996). Routine trimming of 381 
cattle feet has also been reported as a risk factor by Barker and others (2007) and Espejo and Andres 382 
(2007) in observational studies, but as protective factor in a controlled trial by Manske and others 383 
(2002). 384 
 385 
19.3. Specificity 386 
 387 
Is the exposure specific to one disease? To my knowledge, there is no association between 388 
foot trimming and other diseases than footrot - but this is hardly surprising, maybe once CODD has 389 
been more widely studied we might see a link between these diseases.  390 
 391 
19.4. Temporality 392 
 393 
Does the association occur before the disease? This is where study design becomes important 394 
and cross sectional studies (Table 3) are less useful, unless the exposure is not time dependent. For 395 
example, if a certain breed or sex is more likely to get a disease, then time is less important. For 396 
footrot, the studies of those by Jordan and others (1996) and Green and others (2007) are temporally 397 
robust. 398 
 399 
19.5. Biological gradient 400 
 401 
That is, is there a dose-response, i.e. more exposure gives a stronger measure of association. 402 
For the foot trimming and footrot studies, this association is present in observational studies, where 403 
the more frequently a flock was trimmed, the higher the peak prevalence of footrot (Wassink et al., 404 
2003), but has not been done in clinical trials.  405 
 406 
 407 
 408 
 409 
19.6. Plausibility 410 
 411 
Is the causation biologically plausible? This is interesting, but I think a challenging question, 412 
because it is possible to make most things ‘plausible’ or ‘implausible’! So, we can hypothesise that 413 
trimming feet either makes the sheep trimmed more susceptible to invasion with D. nodosus (the 414 
micro-organism causing footrot) or more infectious to other sheep in the group or that trimming is not 415 
causal, but is a correlate for not treating footrot in individuals (for which there is strong evidence for 416 
efficacy of antibacterial treatment (Jordan et al., 1996; Grogono Thomas et al., 2003; Kaler and Green, 417 
2008; Kaler et al., 2009)).  418 
 419 
19.7. Coherence 420 
 421 
Cause-and-effect should not seriously conflict with the ‘generally known facts of the natural 422 
history and biology of the disease’. The tradition for foot trimming sheep feet probably comes from 423 
the pre-antibiotic era, when exposing D. nodosus to air killed this facultative anaerobe (Mohler and 424 
Washburn, 1904). Its logic, now that parenteral administration of antibacterial agents is available, is 425 
less robust. Indeed, anecdotally expert practitioners are now promoting foot trimming to maintain foot 426 
shape (Winter, 2008) rather than the traditional recommendation that it controls footrot (Morgan, 427 
1987; Winter, 2003; ).  428 
 429 
19.8. Experiment 430 
 431 
A well designed experiment that demonstrates statistical association gives a strong inference 432 
for causality. If it is of sufficient power, well designed and well run (Thrusfield, 1995), then a 433 
comparison between treatment and control is most useful. This has been done by Jordan and others 434 
(1996). 435 
 436 
19.9. Analogy 437 
 438 
We can sometimes use judgement by analogy. That is, if we have seen an association in one 439 
situation that was causal, then we can accept slighter but similar evidence in another. I cannot think of 440 
an example for footrot, but if, for example, the evidence continues to grow and we do move towards 441 
accepting that foot trimming feet is detrimental to cure and control of footrot in sheep, we might be 442 
ready to accept evidence that it is also detrimental to treatment and control of contagious ovine digital 443 
dermatitis, another infectious disease of the hoof in sheep, if some preliminary evidence became 444 
available. 445 
 446 
It is remarkable that there are so few sheep diseases where causes can be assessed on all of the 447 
above. This does mean that we need an open mind when we think about disease and maybe a good 448 
starting point is that the point of science is to disprove rather than prove. If we are prepared for our 449 
current assumptions to be disproved, our minds can be opened up to a wide range of possibilities. One 450 
example from my career that uses some of the considerations on causality occurred during my PhD. I 451 
studied lambs reared in straw-bedded barns from birth to slaughter. These lambs never went out to 452 
pasture. At 3 to 4 weeks of age, many lambs had a non-regenerative anaemia typical of iron 453 
deficiency, when compared with outdoor reared lambs of the same age (Green et al., 1994). Iron 454 
deficiency seemed likely, because we know that piglets and calves reared without contaminant iron 455 
from soil develop iron deficiency anaemia, because the demands for iron are high with the 456 
physiological change from foetal to adult haemoglobin (Coherence, Plausibility, Analogy). The lambs 457 
haematological values were within the normal range quoted in the reference manual (Schalm, 1981), 458 
but in the original article used for these values lambs were housed in straw-bedded barns and some 459 
were removed from the study because they were anaemic (!) (Consistency). A within farm clinical 460 
trial run in 1994, where 50% of lambs were given with iron dextran soon after birth, prevented this 461 
anaemia and lambs grew faster to weaning (Green et al., 1997b) (Experiment, Temporality, 462 
Specificity). The paper by Green and others (1997b) was rejected initially, because the reviewers 463 
rejected the recommendation that lambs born and housed indoors (even for a few weeks after birth 464 
when foetal haemoglobin changes to adult haemoglobin) should receive external iron. This paper was 465 
finally published when a smaller study that reported similar results was published (Bassett et al., 466 
1995) and the editor revised his opinion. The reviewers that rejected the paper by Green and others 467 
(1997b) initially did so from their opinion on the management of lambs and not from the scientific 468 
evidence or iron deficiency. This takes us nicely back to evidence-based medicine, where there are 469 
two aspects to consider, one is the evidence base and one is a clinician’s knowledge of a flock and its 470 
carers. I strongly believe that new scientific evidence should be published and I think that there is 471 
strong evidence that lambs reared in the absence of soil for their first week of life can become 472 
deficient in iron. How one manages this in a flock, whether by supplementation or altering exposure to 473 
soil, is a decision for the clinician and carers. 474 
 475 
20. Conclusions 476 
 477 
We use epidemiology in many ways, as we manage sheep diseases from diagnosing disease 478 
and treating individuals to managing flocks and controlling disease. Understanding disease processes, 479 
pathogen behaviour in populations and knowledge to evaluate evidence and test results together with a 480 
good knowledge of our patients can all contribute to good evidence-based management of sheep 481 
health. 482 
 483 
 484 
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Legends of figures 564 
 565 
Fig. 1. Relationship between true disease and apparent disease from diagnostic test. 566 
 567 
Fig. 2a. Predictive value of a test. 568 
 569 
Fig. 2b. Impact of prevalence on PVP and PVN, sensitivity and specificity 99%. 570 
 571 
Fig. 3. Impact of infectious disease on an individual. 572 
 573 
Fig. 4. The link between individuals and the impact of the pathogen (epidemiological parameters). 574 
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 587 
 588 
 589 
Table 1 590 
Possible states of a host as a pathogen cycles through a population 591 
Possible patterns of host state dependent on the infecting pathogen Likely example pathogens 
Susceptible Infected Infectious  Dead Scrapie agent, Mycoplasma bovis 
Susceptible Infected   Dead Scrapie agent 
Susceptible Infected Infective Recovered Immune Rinderpest Virus 
Susceptible Infected Infective Recovered Carrier 
Corynebacterium 
pseudotuberculosis 
Susceptible Infected Infective Recovered Susceptible Dichelobacter nodosus 
Susceptible Infected Infective  Susceptible 
Pathogens causing mastitis (e.g., 
Staphylococcus aureus) 
Susceptible Infected Infective Susceptible 
Partially 
immune 
Nematode helminth infections 
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 615 
Table 2. Epidemiological definitions used in sheep health management 616 
Epidemiology The occurrence, distribution and determinants of disease in a population 
Host The animal infected with a pathogen 
Case definition 
A unique measurable set of criteria for an aspect of production and disease that enables 
us to monitor flock health with precision 
Gold Standard The perfect test to define a disease 
Sensitivity The proportion of individuals that are truly diseased that are positive by the test 
Specificity 
The proportion of individuals that are truly negative to the disease that are negative by 
the test 
Prevalence The amount of disease at one point in time or over a time period 
Incidence The new case rate in a given time 
Predictive value of a 
positive test 
The proportion of test positive individuals that are truly positive 
Predictive value of a 
negative test 
The proportion of test negative individuals that are truly negative 
Measure of effect The magnitude of association between an exposure and a disease 
Exposure Factor possibly associated with a disease  
Eliminate Remove a disease from a selected population (flock, region, country) 
Eradicate Remove a disease from the world 
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 635 
Table 3. Types of study design used in epidemiology 636 
Study type 
Observational or 
experimental 
Association with 
time 
Main uses 
Useful for elucidating 
cause 
Case study Observational None 
Describes a novel 
presentation of 
disease in an 
individual or 
population 
Useful for defining case 
definition for a novel 
disease 
Cross 
sectional 
Observational One point in time 
Estimate prevalence, 
generate hypotheses 
Only for non-time varying 
exposures 
Case control Observational Retrospective 
Identify risks for rare 
diseases 
Reasonable, but risk of 
recall bias 
Cohort Observational 
Prospective or 
occasionally 
retrospective 
Estimate incidence, 
identify risks for more 
common diseases 
Good, because subject 
disease and exposure status 
monitored in real time 
Intervention 
study 
Experimental, unit 
of study might be a 
group 
Prospective 
Investigate impact of 
putative control 
measure 
Very good, because 
comparing a controlled 
situation 
Clinical trial 
Experimental, unit 
more often an 
individual 
 
Investigate impact of 
putative control 
measure 
Very good, because 
comparing a controlled 
situation 
 637 
 638 
639 
Figure 1. Relationship between true disease and apparent disease from diagnostic test.  640 
 641 
 642 
 643 
 644 
 645 
 646 
Black curve = distribution of truly disease free individuals, grey curve = distribution of truly diseased 647 
individuals. Whilst the mean value for the diagnostic test results is different between diseased and 648 
non-diseased, there is an overlap in test results, some individuals with test values 5 – 7 are truly 649 
positive (area under the grey curve), others are truly negative (area under the black curve). If we set 650 
the cut off at 6 we have both false positive and false negative individuals. If we set the cut off at 7 651 
(increasing the test specificity) we have no false positive individuals but many false negatives. If we 652 
set the cut off at 5 (increasing the test sensitivity) we have no false negative individuals but many false 653 
positives. 654 
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Figure 2. Predictive value of a test 657 
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 661 
black = predictive value of a positive test, grey = predictive value of a negative test.  662 
 663 
Figure 2b. Impact of prevalence on PVP and PVN, sensitivity and specificity 99% 664 
 665 
 666 
 667 
black = predictive value of a positive test, grey = predictive value of a negative test.  668 
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Figure 3. Impact of infectious disease on an individual 670 
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Figure 4. The link between individuals and the impact of the pathogen (epidemiological parameters) 677 
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